gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A

Infection and Immunity

Volumn 76, Issue 7, 2008, Pages 2862-2871

  Na, Xi ^a   Kim, Ho ^a   Moyer, Mary P ^b   Pothoulakis, Charalabos ^a   LaMont, J Thomas ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INCELL Corporation ^*  (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; GLYCOPROTEIN GP 96; PROTEIN BAK; SMALL INTERFERING RNA; BACTERIAL TOXIN; ENDOPLASMIN; ENTEROTOXIN; MEMBRANE PROTEIN; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE;

APICAL MEMBRANE; APOPTOSIS; ARTICLE; CELL STRAIN HT29; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DNA FRAGMENTATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INTESTINE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; B LYMPHOCYTE; CELL LINE; CELL MEMBRANE; COLON; CYTOLOGY; EPITHELIUM CELL; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOGENICITY;

B-LYMPHOCYTES; BACTERIAL TOXINS; CELL LINE; CELL MEMBRANE; CLOSTRIDIUM DIFFICILE; COLON; CYTOPLASM; ENTEROTOXINS; EPITHELIAL CELLS; HT29 CELLS; HUMANS; MEMBRANE GLYCOPROTEINS;

EID: 46449130378     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00326-08     Document Type: Article

References (47)

1. Berwin, B., J. P. Hart, S. Rice, C. Gass, S. V. Pizzo, S. R. Post, and C. V. Nicchitta. 2003. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J. 22:6127-6136.
2. Bresnick, E. H., F. C. Dalman, E. R. Sanchez, and W. B. Pratt. 1989. Evidence that the 90-kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticoid receptor. J. Biol. Chem. 264:4992-4997.
3. Cabanes, D., S. Sousa, A. Cebria, M. Lecuit, F. Garcia-Del Portillo, and P. Cossart. 2005. gp96 is a receptor for a novel Listeria monocytogenes virulence factor, Vip, a surface protein. EMBO J. 24:2827-2838.
4. Chen, M. L., C. Pothoulakis, and J. T. LaMont. 2002. Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A. J. Biol. Chem. 277:4247-4254.
5. de Crom, R., R. van Haperen, R. Janssens, P. Visser, R. Willemsen, F. Grosveld, and A. van der Kamp. 1999. gp96/GRP94 is a putative high density lipoprotein-binding protein in liver. Biochim. Biophys. Acta 1437:378-392.
6. Degenhardt, K., R. Sundararajan, T. Lindsten, C. Thompson, and E. White. 2002. Bax and Bak independently promote cytochrome C release from mitochondria. J. Biol. Chem. 277:14127-14134.
7. Dove, C. H., S. Z. Wang, S. B. Price, C. J. Phelps, D. M. Lyerly, T. D. Wilkins, and J. L. Johnson. 1990. Molecular characterization of the Clostridium difficile toxin A gene. Infect. Immun. 58:480-488.
8. Greco, A., J. G. Ho, S. J. Lin, M. M. Palcic, M. Rupnik, and K. K. Ng. 2006. Carbohydrate recognition by Clostridium difficile toxin A. Nat. Struct. Mol. Biol. 13:460-461.
9. Gross, A., J. M. McDonnell, and S. J. Korsmeyer. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1899-1911.
10. Haug, G., K. Aktories, and H. Barth. 2004. The host cell chaperone Hsp90 is necessary for cytotoxic action of the binary iota-like toxins. Infect. Immun. 72:3066-3068.
11. Haug, G., J. Leemhuis, D. Tiemann, D. K. Meyer, K. Aktories, and H. Barth. 2003. The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol. J. Biol. Chem. 278: 32266-32274.
12. He, D., S. Sougioultzis, S. Hagen, J. Liu, S. Keates, A. C. Keates, C. Pothoulakis, and J. T. Lament. 2002. Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation. Gastroenterology 122:1048-1057.
13. Ho, J. G., A. Greco, M. Rupnik, and K. K. Ng. 2005. Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc. Natl. Acad. Sci. USA 102:18373-18378.
14. Hofmann, F., C. Busch, and K. Aktories. 1998. Chimeric clostridial cytotoxins: identification of the N-terminal region involved in protein substrate recognition. Infect. Immun. 66:1076-1081.
15. Hofmann, F., C. Busch, U. Prepens, I. Just, and K. Aktories. 1997. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J. Biol. Chem. 272:11074-11078.
16. Hornef, M. W., B. H. Normark, A. Vandewalle, and S. Normark. 2003. Intracellular recognition of lipopolysaccharide by Toll-like receptor 4 in intestinal epithelial cells. J. Exp. Med. 198:1225-1235.
17. Just, I., J. Selzer, M. Wilm, C. von Eichel-Streiber, M. Mann, and K. Aktories. 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375:500-503.
18. Just, I., M. Wilm, J. Selzer, G. Rex, C. von Eichel-Streiber, M. Mann, and K. Aktories. 1995. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem. 270:13932-13936.
19. Karumanchi, S. A., V. Jha, R. Ramchandran, A. Karihaloo, L. Tsiokas, B. Chan, M. Dhanabal, J. I. Hanai, G. Venkataraman, Z. Shriver, N. Keiser, R. Kalluri, H. Zeng, D. Mukhopadhyay, R. L. Chen, A. D. Lander, K. Hagihara, Y. Yamaguchi, R. Sasisekharan, L. Cantley, and V. P. Sukhatme. 2001. Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell 7:811-822.
20. Kelly, C. P., C. Pothoulakis, and J. T. LaMont. 1994. Clostridium difficile colitis. N. Engl. J. Med. 330:257-262.
21. Kim, H., E. Kokkotou, X. Na, S. H. Rhee, M. P. Moyer, C. Pothoulakis, and J. T. Lamont. 2005. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Gastroenterology 129:1875-1888.
22. Kim, H., S. H. Rhee, E. Kokkotou, X. Na, T. Savidge, M. P. Moyer, C. Pothoulakis, and J. T. LaMont. 2005. Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. J. Biol. Chem. 280: 21237-21245.
23. Koike, C., J. J. Fung, D. A. Geller, R. Kannagi, T. Libert, P. Luppi, I. Nakashima, J. Profozich, W. Rudert, S. B. Sharma, T. E. Starzl, and M. Trucco. 2002. Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J. Biol. Chem. 277:10114-10120.
24. Krivan, H. C., G. F. Clark, D. F. Smith, and T. D. Wilkins. 1986. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Galα1-3Galβ1-4GlcNAc. Infect. Immun. 53:573-581.
25. Li, Z., J. Dai, H. Zheng, B. Liu, and M. Caudill. 2002. An integrated view of the roles and mechanisms of heat shock protein gp96-peptide complex in eliciting immune response. Front Biosci. 7:d731-d751.
26. Liu, T. S., M. W. Musch, K. Sugi, M. M. Walsh-Reitz, M. J. Ropeleski, B. A. Hendrickson, C. Pothoulakis, J. T. Lamont, and E. B. Chang. 2003. Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunction. Am. J. Physiol. Cell Physiol. 284:C1073-C1082.
27. Lyerly, D. M., K. E. Saum, D. K. MacDonald, and T. D. Wilkins. 1985. Effects of Clostridium difficile toxins given intragastrically to animals. Infect. Immun. 47:349-352.
28. Maki, R. G., L. J. Old, and P. K. Srivastava. 1990. Human homologue of murine tumor rejection antigen gp96: 5′-regulatory and coding regions and relationship to stress-induced proteins. Proc. Natl. Acad. Sci. USA 87:5658-5662.
29. Mitchell, T. J., J. M. Ketley, S. C. Haslam, J. Stephen, D. W. Burden, D. C. Candy, and R. Daniel. 1986. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut 27:78-85.
30. Moncrief, J. S., and T. D. Wilkins. 2000. Genetics of Clostridium difficile toxins. Curr. Top. Microbiol. Immunol. 250:35-54.
31. Na, X., D. Zhao, H. W. Koon, H. Kim, J. Husmark, M. P. Moyer, C. Pothoulakis, and J. T. LaMont. 2005. Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes. Gastroenterology 128:1002-1011.
32. Pothoulakis, C., R. J. Gilbert, C. Cladaras, I. Castagliuolo, G. Semenza, Y. Hitti, J. S. Montcrief, J. Linevsky, C. P. Kelly, S. Nikulasson, H. P. Desai, T. D. Wilkins, and J. T. LaMont. 1996. Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. J. Clin. Investig. 98:641-649.
33. Pothoulakis, C., and J. T. LaMont. 1993. Clostridium difficile colitis and diarrhea. Gastroenterol. Clin. N. Am. 22:623-637.
34. Prasadarao, N. V., P. K. Srivastava, R. S. Rudrabhatla, K. S. Kim, S. H. Huang, and S. K. Sukumaran. 2003. Cloning and expression of the Escherichia coli K1 outer membrane protein A receptor, a gp96 homologue. Infect. Immun. 71:1680-1688.
35. Randow, F., and B. Seed. 2001. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nat. Cell Biol. 3:891-896.
36. Riegler, M., R. Sedivy, C. Pothoulakis, G. Hamilton, J. Zacherl, G. Bischof, E. Cosentini, W. Feil, R. Schiessel, J. T. LaMont, et al. 1995. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J. Clin. Investig. 95:2004-2011.
37. Schild, H., and H. G. Rammensee. 2000. gp96 - the immune system's Swiss army knife. Nat. Immunol. 1:100-101.
38. Srivastava, P. K., and R. J. Amato. 2001. Heat shock proteins: the "Swiss Army Knife" vaccines against cancers and infectious agents. Vaccine 19:2590-2597.
39. Srivastava, P. K., A. Menoret, S. Basu, R. J. Binder, and K. L. McQuade. 1998. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8:657-665.
40. Suriano, R., S. K. Ghosh, B. T. Ashok, A. Mittelman, Y. Chen, A. Banerjee, and R. K. Tiwari. 2005. Differences in glycosylation patterns of heat shock protein, gp96: implications for prostate cancer prevention. Cancer Res. 65:6466-6475.
41. Triadafilopoulos, G., C. Pothoulakis, M. J. O'Brien, and J. T. LaMont. 1987. Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology 93:273-279.
42. von Eichel-Streiber, C., R. Laufenberg-Feldmann, S. Sartingen, J. Schulze, and M. Sauerborn. 1990. Cloning of Clostridium difficile toxin B gene and demonstration of high N-terminal homology between toxin A and B. Med. Microbiol. Immunol. (Berl.) 179:271-279.
43. von Eichel-Streiber, C., M. Sauerborn, and H. K. Kuramitsu. 1992. Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases. J. Bacteriol. 174:6707-6710.
44. Warny, M., A. C. Keates, S. Keates, I. Castagliuolo, J. K. Zacks, S. Aboudola, A. Qamar, C. Pothoulakis, J. T. LaMont, and C. P. Kelly. 2000. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J. Clin. Investig. 105:1147-1156.
45. Wei, M. C., T. Lindsten, V. K. Mootha, S. Weiler, A. Gross, M. Ashiya, C. B. Thompson, and S. J. Korsmeyer. 2000. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14:2060-2071.
46. Wei, M. C., W. X. Zong, E. H. Cheng, T. Lindsten, V. Panoutsakopoulou, A. J. Ross, K. A. Roth, G. R. MacGregor, C. B. Thompson, and S. J. Korsmeyer. 2001. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730.
47. Zong, W. X., T. Lindsten, A. J. Ross, G. R. MacGregor, and C. B. Thompson. 2001. BH3-only proteins that bind prosurvival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15:1481-1486.